How is lung parasitosis treated?

Update Date: 2022-11-25 Source: Network

summary

With the development of industrialization in China, the number of people suffering from lung cancer is increasing. Among the male patients who died of cancer, lung cancer is the first. More than 40 years ago, in China, the vast majority of patients undergoing surgical treatment for lung diseases were pulmonary tuberculosis, followed by bronchiectasis, lung abscess and other pulmonary suppurative infections, and the number of cases of pulmonary parasitic diseases was small. So we must do a good job of this disease related work, then how to treat pulmonary parasitic disease?.

How is lung parasitosis treated?

First, as long as it is a drug, it will have positive and negative effects. Unlike cytotoxic chemotherapy drugs, targeted drugs for pulmonary parasitic diseases have obvious side effects such as gastrointestinal reactions, bone marrow suppression, epithelial shedding and hair loss. There are two main side effects of targeted drugs for lung cancer. One is the so-called skin rash reaction, and some are acne like manifestations. Another is mild diarrhea, some patients can not tolerate diarrhea and stop taking drugs.

Second, the guidelines for the clinical diagnosis and treatment of adverse skin reactions of molecular targeted drugs for pulmonary parasitic diseases in China have been formulated. Oncologists and dermatologists should summarize some principles for the treatment of side effects of molecular targeted drugs in the diagnosis and treatment of lung cancer.

Third: in fact, there are many clinical research data that show that rash is not a bad thing. On the one hand, it proves that you are the beneficiary, and at present, there are also good treatments. As for diarrhea symptoms, there are many corresponding symptomatic treatment drugs.

matters needing attention

At present, chemotherapy is the main treatment for patients with advanced pulmonary parasitic diseases. However, the main reason for the failure of chemotherapy is the resistance of lung parasite cells to anticancer drugs.